Long-Term Maintenance of Peanut Oral Immunotherapy in Patients Ages 4 and Older

Peanut oral immunotherapy (OIT) in patients ≥4 years old is generally considered long-term treatment that requires prolonged, daily ingestion to maintain the desensitized state. Due to the risks, requirements, and constraints associated with daily dosing, we sought to determine the number of patients ≥4 years old who were continuing treat ment at least one year after reaching maintenance.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research